Cargando…

Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination

Vaccination has made a substantial contribution to global health improvement throughout history. The coronavirus disease 2019 (COVID-19) vaccinations have provided us with a ray of hope for combatting the ongoing pandemic and saving lives. However, following COVID-19 vaccination, a wide spectrum of...

Descripción completa

Detalles Bibliográficos
Autor principal:	Shanshal, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329707/ https://www.ncbi.nlm.nih.gov/pubmed/35911257 http://dx.doi.org/10.7759/cureus.26383

Ejemplares similares

Dyshidrosiform Bullous Pemphigoid: Case Reports and Review
por: Cohen, Philip R
Publicado: (2020)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

Eruptive Angiomatosis Triggered by COVID-19 Vaccination
por: Shanshal, Mohammed
Publicado: (2022)

Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
por: Viglizzo, Gianmaria, et al.
Publicado: (2022)

Hemorrhagic vesiculobullous eruption on the palms and the soles as presentation of dyshidrosiform bullous pemphigoid
por: Michelerio, Andrea, et al.
Publicado: (2017)

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

The Successful Treatment of COVID-19-Induced Bullous Pemphigoid With Dupilumab
por: Savoldy, Michelle A, et al.
Publicado: (2022)

Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022)

Combination Therapy of Plasma Exchange and Rituximab to Treat Cicatricial Pemphigoid and Bullous Pemphigoid
por: Kunadia, Anuj, et al.
Publicado: (2021)

Delayed Onset of Bullous Pemphigoid Secondary to Nivolumab
por: Olsen, Eric, et al.
Publicado: (2023)

A Case of Bullous Pemphigoid Associated With Nivolumab Therapy
por: Gotera, Nico, et al.
Publicado: (2022)

Hydrochlorothiazide vs Venlafaxine: Drug-induced Bullous Pemphigoid
por: Naramala, Srikanth, et al.
Publicado: (2019)

A Case of Severe Bullous Dermatitis With Mixed Bullous Pemphigoid and Pemphigus Vulgaris Cutaneous Manifestations
por: Burns, Reece D, et al.
Publicado: (2021)

A Case of Drug-Induced Bullous Pemphigoid With an Isomorphic Response and Updated Review of Koebnerization in Bullous Diseases
por: Ambur, Austin B, et al.
Publicado: (2021)

Dyshidrosiform pemphigoid with Parkinsonism in a nonagenarian Maharashtrian female
por: Behlim, Tabassum, et al.
Publicado: (2014)

A Case of Bullous Pemphigoid: A Prevalent and Potentially Fatal Condition
por: Parellada, Jorge, et al.
Publicado: (2018)

Bullous Pemphigoid in a Centenarian Male Simulating Toxic Epidermal Necrolysis
por: Shakhashiro, Muna, et al.
Publicado: (2023)

Bullous Pemphigoid: A Spontaneous Presentation in a Patient With Chronic Kidney Disease
por: Brazen, Brett, et al.
Publicado: (2022)

Association of Bullous Pemphigoid with Malignancy: A Myth or Reality?
por: Fernandes, Joycelin, et al.
Publicado: (2014)

Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid
por: Chen, Fangyuan, et al.
Publicado: (2023)

Bullous Pemphigoid and Human Leukocyte Antigen (HLA)-DQA1: A Systematic Review
por: Hesari, Roksana, et al.
Publicado: (2023)

Bullous Pilomatrixoma After COVID-19 Vaccination
por: Alvarez-Rubio, Francisco Javier, et al.
Publicado: (2022)

A Rare Case of Bullous Pemphigoid Secondary to Checkpoint Inhibitor Immunotherapy: A Tense Situation
por: Wesolow, Jacqueline T, et al.
Publicado: (2021)

A Case of Bullous Pemphigoid in a Five-Month-Old Female: A Rare Presentation
por: Ahmed, Mohamed, et al.
Publicado: (2023)

Dyshidrosiform pemphigoid localized on the hands in a child: a rare occurrence
por: Dayal, Surabhi, et al.
Publicado: (2017)

Bullous Pemphigoid Associated With Pembrolizumab Therapy for Non-Small-Cell Lung Cancer: A Case Report
por: Chatterjee, Tulika, et al.
Publicado: (2022)

COVID-19 and Herpes Simplex Virus Infection: A Cross-Sectional Study
por: Shanshal, Mohammed, et al.
Publicado: (2021)

Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England
por: Persson, Monica S M, et al.
Publicado: (2020)

Bullous Pemphigoid Limited to the Hands and Feet: A Rare Case of an Infantile Disease Pattern Seen in an Elderly Patient
por: Nellore, Aditya, et al.
Publicado: (2023)

Bullous pemphigoid and COVID-19 vaccine()
por: Pérez-López, Israel, et al.
Publicado: (2021)

Bullous pemphigoid triggered by COVID‐19 vaccine: Rapid resolution with corticosteroid therapy
por: Dell'Antonia, Massimo, et al.
Publicado: (2021)

Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five Cases
por: Hali, Fouzia, et al.
Publicado: (2022)

Bullous Pemphigoid: Trigger and Predisposing Factors
por: Moro, Francesco, et al.
Publicado: (2020)

May bullous pemphigoid be worsened by COVID-19 vaccine?
por: Cozzani, Emanuele, et al.
Publicado: (2022)

Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
por: Rosińska-Więckowicz, Anna, et al.
Publicado: (2021)

New‐onset bullous pemphigoid and flare of pre‐existing bullous pemphigoid after the third dose of the COVID‐19 vaccine
por: Bardazzi, Federico, et al.
Publicado: (2022)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Vitiligo Possibly Triggered by COVID-19 Vaccination
por: Militello, Michelle, et al.
Publicado: (2022)

Bullous Iodide Rash
Publicado: (1909)

The Impact of the Initial Phase of the COVID-19 Pandemic on Patients With Autoimmune Bullous Diseases
por: Örnek, Sinem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ha1sv7gk26unpvbvp9kvujjab6